Search results
Tematy dnia
28 lis 2023 · The authors argue that putting the specific needs of individuals and communities at the heart of HIV/AIDS care, by harnessing behavioural science, is key to building on the progress already been made. They cite Botswana as a model for reaching the 95-95-95 targets and highlight the challenges and opportunities for young people and other populations at risk.
Scientists say they have successfully eliminated HIV from infected cells, using Nobel Prize-winning Crispr gene-editing technology. Working like scissors, but at the molecular level, it cuts DNA...
8 sie 2024 · Aug. 8, 2024. Scientists have developed a new weapon against H.I.V.: a molecular mimic that invades a cell and steals essential proteins from the virus. A study published in Science on Thursday...
10 lip 2024 · Gilead Sciences' trial results show that Lenacapavir, an injectable long-acting HIV medicine, is highly effective for preventing HIV infections. UNAIDS calls on Gilead to ensure equitable global access to the medicine through generic production and voluntary licensing agreements.
25 lip 2024 · A 60-year-old German man living with HIV achieved sustained HIV remission after a stem cell transplant from a donor with a rare genetic mutation. This is the seventh case of potential HIV cure and fuels optimism for an eventual HIV cure, but more research is needed.
Scientists say they have successfully eliminated HIV from infected cells, using Nobel Prize-winning Crispr gene-editing technology.
5 sie 2022 · Cabotegravir, an injectable antiviral, provides stronger protection than oral pill, but its price could be too high for low-income countries. The drug is manufactured by ViiV Healthcare, which has announced a voluntary licensing agreement for generic versions in 90 countries.
